AiViva Biopharma completes enrollment in Phase 1 clinical trial of AIV007 for AMD, DME
By David Hutton The Phase 1 trial is a multicenter, open-label, dose-escalation safety clinical trial, with 18 subjects, who each have received a single periocular injection of AIV007 AiViva Biopharma Inc…